Paricalcitol (Hospira, Inc.)
Welcome to the PulseAid listing for the Paricalcitol drug offered from Hospira, Inc.. This Cholecalciferol [Chemical/Ingredient],Vitamin D3 Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | PARICALCITOL |
SUBSTANCE NAME: | PARICALCITOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholecalciferol [Chemical/Ingredient],Vitamin D3 Analog [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-12-01 |
END MARKETING DATE: | 0000-00-00 |
Paricalcitol HUMAN PRESCRIPTION DRUG Details:
Item Description | Paricalcitol from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(ug/mL) |
START MARKETING DATE: | 2014-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-1007_0acd0290-8b34-4545-a538-8b47797dabdd |
PRODUCT NDC: | 0409-1007 |
APPLICATION NUMBER: | NDA201657 |
Other PARICALCITOL Pharmaceutical Manufacturers / Labelers: